Brensocatib
- Generic Name
- Brensocatib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24N4O4
- CAS Number
- 1802148-05-5
- Unique Ingredient Identifier
- 25CG88L0BB
- Background
Brensocatib is under investigation in clinical trial NCT03218917 (Assessment of INS1007 in Subjects With Non-cystic Fibrosis Bronchiectasis).
- Indication
用于非囊性纤维化支气管扩张症（NCFBE）成人患者的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 406
- Registration Number
- NCT04817332
- Locations
- 🇬🇧
Frimley Health NHS Foundation Trust, Frimley, United Kingdom
🇬🇧Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
🇬🇧NHS Fife, Dunfermline, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath